Header image

Plenary 4: Elimination: How and what are we achieving? Evaluation and Surveillance

Friday, August 11, 2017
8:30 AM - 10:00 AM
Tully Room I - III

Speaker

Agenda Item Image
Associate Professor Rebecca Guy
Program Head And Profesorgoram
Kirby Institute, UNSW, Sydney, Australia

Keynote 6 : Tracking Progress towards Elimination

8:30 AM - 9:00 AM

Video Presentation

Biography

A/Professor Rebecca Guy holds a PhD in epidemiology, and a Masters of Applied Epidemiology. She has worked at the Sexual Health Program at Kirby Institute, UNSW, since 2008 and in 2015 was appointed Head of the Surveillance, Evaluation and Research Program. Her research focuses on the epidemiology and prevention of sexually transmissible infections. She has led a large number of collaborative studies, particularly in the area of clinical and public health interventions, which include: large-scale epidemiological studies involving complex surveillance systems; the evaluation of STI control strategies; and rapid point-of-care tests for STIs in remote and developing country settings.
Agenda Item Image
Dr Homie Razavi
Managing Director
Center For Disease Analysis

Global burden of hepatitis & use of pooled procurement to expand access

9:00 AM - 9:25 AM

Speaker Presentation

Video Presentation

Biography

Homie is the managing director at the Center for Disease Analysis (CDA) and CDA Foundation. He also leads the Polaris Observatory and the Global Procurement Fund (GPRO) which provides up to date epidemiology data and a mean of purchasing affordable quality treatment and diagnostics.
Professor Ed Gane
Hepatologist
Auckland City Hospital

Where is New Zealand in the race to eliminate Hepatitis C?

9:25 AM - 9:35 AM

Speaker Presentation

Video Presentation

Biography

Ed is Professor of Medicine at the University of Auckland. Ed chairs the Ministry of Health Hepatitis C Implementation Committee, responsible for rolling out community-based targeted testing and treatment. Ed is an investigator for many international clinical trials of new direct acting antiviral therapies for chronic hepatitis C. Ed has published almost 300 papers in peer-reviewed journals including Lancet and New England Journal of Medicine.

Chair

John Chen Hsiang
Specialist
Changi General Hospital

Agenda Item Image
Alisa Pedrana
Eliminate Hepatitis C Australia Coordinator
Burnet Institute





loading